(1-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroquinolin-6-yl)boronic acid

98%

  • Product Code: 152135
  CAS:    1260150-04-6
Molecular Weight: 277.12 g./mol Molecular Formula: C₁₄H₂₀BNO₄
EC Number: MDL Number: MFCD06801709
Melting Point: Boiling Point: 453.3±55.0 °C(Predicted)
Density: 1.21±0.1 g/cm3(Predicted) Storage Condition: 2-8°C, Inert Gas
Product Description: Used as a key intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other biologically active compounds. Its boronic acid functionality enables participation in Suzuki-Miyaura cross-coupling reactions, allowing for efficient formation of carbon-carbon bonds in complex molecule assembly. Commonly employed in medicinal chemistry for structure-activity relationship studies due to the stability and reactivity of the boronic acid group. The tert-butoxycarbonyl (Boc) protecting group enhances solubility and stability during reaction sequences, making it suitable for multi-step syntheses. Frequently utilized in the preparation of drug candidates targeting cancer, inflammation, and central nervous system disorders.
Sizes / Availability / Pricing:
Size Availability Price Quantity
0.100 10-20 days $80.82
+
-
0.250 10-20 days $154.91
+
-
1.000 10-20 days $526.38
+
-
5.000 10-20 days $2,281.67
+
-
(1-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroquinolin-6-yl)boronic acid
Used as a key intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other biologically active compounds. Its boronic acid functionality enables participation in Suzuki-Miyaura cross-coupling reactions, allowing for efficient formation of carbon-carbon bonds in complex molecule assembly. Commonly employed in medicinal chemistry for structure-activity relationship studies due to the stability and reactivity of the boronic acid group. The tert-butoxycarbonyl (Boc) protecting group enhances solubility and stability during reaction sequences, making it suitable for multi-step syntheses. Frequently utilized in the preparation of drug candidates targeting cancer, inflammation, and central nervous system disorders.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...

Cart

No products

Subtotal: $0.00
$0.00 Total :

The availability date depends on real-time stock, and any changes after payment will be notified within 30 minutes
You can choose the delivery date on the next page